Family Medicine · Dothan, AL
NPI
1063851277
Since 2013
Specialty
Family Medicine
Code 207Q00000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
201 Doctors Drive
Dothan, AL, 36301
Phone (334) 794-6612
Groups this clinician bills Medicare through
Medicare paid, 2024
$475K
18,199 services
Medicare patients, 2024
1,117
Average age 75
Drug cost, 2024
$5.4M
62,211 prescriptions
Company payments, 2025
$510
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carlos S Clark II was code J1010 (injection, methylprednisolone acetate, 1 mg), 4,685 times for 97 patients. In total Carlos S Clark II billed 18,199 services in 105 codes, and Medicare paid $475K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-08-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 4,685 | 97 | $0.10 | $470 |
| 99308 SNF E&M | Office | 1,705 | 143 | $51.24 | $87K |
| 99214 Office E&M - Established | Office | 1,297 | 508 | $83.46 | $108K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 768 | 146 | $0.08 | $62.86 |
| 80053 Clinical Chemistry | Office | 551 | 323 | $10.33 | $5,693 |
| 85025 Blood Count | Office | 530 | 312 | $7.60 | $4,026 |
| 84443 Clinical Chemistry | Office | 485 | 299 | $16.33 | $7,919 |
| 83036 Blood Count | Office | 463 | 296 | $9.49 | $4,394 |
| 80061 Clinical Chemistry | Office | 451 | 299 | $12.98 | $5,854 |
| 96372 Injection Administration | Office | 444 | 205 | $9.68 | $4,297 |
| 82607 Clinical Chemistry | Office | 434 | 290 | $14.65 | $6,360 |
| 84439 Clinical Chemistry | Office | 422 | 260 | $8.80 | $3,715 |
| 84481 Clinical Chemistry | Office | 413 | 258 | $16.51 | $6,817 |
| 81001 Clinical Chemistry | Office | 408 | 262 | $3.10 | $1,265 |
| 82306 Clinical Chemistry | Office | 402 | 267 | $28.83 | $12K |
By year: 2022 $408K for 11,089 services; 2023 $435K for 10,645 services; 2024 $475K for 18,199 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 551 | 323 | $10.33 | $5,693 |
| 85025 Blood Count | 530 | 312 | $7.60 | $4,026 |
| 84443 Clinical Chemistry | 485 | 299 | $16.33 | $7,919 |
| 83036 Blood Count | 463 | 296 | $9.49 | $4,394 |
| 80061 Clinical Chemistry | 451 | 299 | $12.98 | $5,854 |
| 82607 Clinical Chemistry | 434 | 290 | $14.65 | $6,360 |
| 84439 Clinical Chemistry | 422 | 260 | $8.80 | $3,715 |
| 84481 Clinical Chemistry | 413 | 258 | $16.51 | $6,817 |
| 81001 Clinical Chemistry | 408 | 262 | $3.10 | $1,265 |
| 82306 Clinical Chemistry | 402 | 267 | $28.83 | $12K |
Medicare prescription drug claims, 2024
In 2024, the drug Carlos S Clark II prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,577 prescriptions and refills. In total Carlos S Clark II wrote 62,211 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,577 | 3,768 | 432 | $45K |
| Amlodipine Besylate Generic | 2,061 | 2,875 | 338 | $22K |
| Levothyroxine Sodium Generic | 1,971 | 2,711 | 260 | $23K |
| Pantoprazole Sodium Generic | 1,841 | 2,491 | 336 | $43K |
| Gabapentin Generic | 1,648 | 1,838 | 300 | $29K |
| Potassium Chloride Generic | 1,572 | 1,902 | 240 | $46K |
| Eliquis Apixaban | 1,443 | 1,539 | 128 | $557K |
| Furosemide Generic | 1,393 | 1,522 | 202 | $8,718 |
| Losartan Potassium Generic | 1,266 | 1,953 | 234 | $17K |
| Lisinopril Generic | 1,060 | 1,616 | 189 | $10K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,008 | 1,009 | 191 | $24K |
| Trazodone Hcl Generic | 982 | 1,140 | 165 | $13K |
| Mirtazapine Generic | 966 | 1,005 | 142 | $20K |
| Carvedilol Generic | 926 | 1,210 | 144 | $16K |
| Metformin Hcl Generic | 908 | 1,275 | 171 | $12K |
Brand drugs: 9,123 claims; generic drugs: 52,914 claims; opioid claims: 2,174.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carlos S Clark II $510 ($510 in general payments such as food, travel and fees) from 13 companies. The largest payer was Amgen Inc. with $83.59.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 5 | $83.59 |
| GlaxoSmithKline, LLC. GSK | 4 | $74.17 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $68.64 |
| Medtronic, Inc. MDT | 1 | $59.46 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $46.56 |
| Inspire Medical Systems, Inc. INSP | 2 | $42 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $33.94 |
| Pfizer Inc. PFE | 1 | $19.88 |
| Abbvie Inc. ABBV | 1 | $18.23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.